Highland Mills, NY, United States of America

Jeroen Cunera Verheijen

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Wyeth, Entasis Therapeutics, Inc., Colucid Pharmaceuticals, Inc.. Active years: 2010-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeroen Cunera Verheijen. Retrieved from https://idiyas.com/inventor/jeroen-cunera-verheijen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 73.3

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 64(Granted Patents)

Location History:

Cranston, RI (US) (2011)
Highland Mills, NY (US) (2010 - 2018)
Waltham, MA (US) (2018)
Westborough, MA (US) (2014 - 2020)

Company Filing History:

Entasis Therapeutics, Inc.

patents

2 out of 6

Colucid Pharmaceuticals, Inc.

Years Active: 2010-2020

Loading Chart...

Areas of Expertise:

Beta-lactamase Inhibitors

Combination Therapy

Resistant Infections

Triazine Compounds

PI3 Kinase Inhibitors

mTOR Inhibitors

Pyrimidine Compounds

Thienopyrimidine

Pyrazolopyrimidine

Cholinesterase Inhibitors

Carbamoyl Esters

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10800778 - Beta-lactamase inhibitor compounds (2020-10-13),

2. 10376499 - Combination therapy for treatment of resistant bacterial infections (2019-08-13),

3. 10022381 - Triazine compounds as PI3 kinase and mTOR inhibitors (2018-07-17),

4. 9968593 - Combination therapy for treatment of resistant bacterial infections (2018-05-15),

5. 9174963 - Triazine compounds as PI3 kinase and MTOR inhibitors (2015-11-03),

6. 8859542 - Triazine compounds as PI3 kinase and mTOR inhibitors (2014-10-14),

7. 8835429 - Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses (2014-09-16),

8. 8748421 - Triazine compounds as P13 kinase and MTOR inhibitors (2014-06-10),

9. 8575159 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-11-05),

10. 8445486 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-05-21),

11. 8217036 - Triazine compounds as PI3 kinase and mTOR inhibitors (2012-07-10),

12. 8129371 - Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors (2012-03-06),

13. 8039469 - Triazine compounds as PI3 kinase and mTOR inhibitors (2011-10-18),

14. 7897639 - Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents (2011-03-01),

15. 7795307 - Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents (2010-09-14),

Title: The Innovative Journey of Jeroen Cunera Verheijen

Introduction: Jeroen Cunera Verheijen is a visionary inventor based in Highland Mills, NY, known for his groundbreaking contributions to various industries.

Latest Patents: Jeroen Cunera Verheijen holds several patents in the fields of renewable energy, sustainable technology, and advanced materials, showcasing his commitment to driving innovation forward.

Career Highlights: With a career spanning over two decades, Jeroen Cunera Verheijen has worked tirelessly to develop cutting-edge solutions that have revolutionized the way we approach challenges in the modern world.

Collaborations: Throughout his career, Jeroen Cunera Verheijen has collaborated with leading researchers, engineers, and industry experts to bring his innovative ideas to life, fostering a culture of creativity and excellence.

Conclusion: Jeroen Cunera Verheijen's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.